Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05697406

HP Pyruvate MRI in Cancers

Conditions: Image, Warburg Effect, Tumors

Sex: All
Ages: 18 Years – 88 Years
Phase: PHASE1, PHASE2
Enrollment: 25
Sponsor: University of Maryland, Baltimore

Location: United States

Summary

Many human diseases are characterized by their ability to alter existing metabolic pathways and interrupt cellular processes. Cancer exploits the Warburg effect and utilizes greater glucose than normal cells and within this process uses anaerobic respiration, leading to increased conversion of pyruvate to lactate. This can be exploited by hyperpolarized imaging. Hyperpolarized 13C MRI imaging is an approach that utilizes a stable isotope of Carbon (13C) linked to pyruvate. MRI spectroscopy is used in conjunction with hyperpolarized 13C pyruvate in order to temporally detect pyruvate and its conversion to lactate in-vivo, in order to visualize downstream metabolic (glycolytic) activity secondary to the Warburg effect, which should be useful in detecting and characterizing tumors of various types. Hyperpolarized 13C pyruvate MR imaging has not been tested in most cancers. In this preliminary survey, we will test the hypothesis that hyperpolarized 13C pyruvate MR imaging can be used to image various cancers.

Eligibility Criteria

Inclusion Criteria:Clinical tumor diagnosisPatients with pre-existing MR imaging appointmentsMust be able to undergo MRExclusion Criteria:No tumor diagnosis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05697406). StuddyBuddy aggregates publicly available trial information.